.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Federal Trade Commission
US Department of Justice
UBS
Covington
Chubb
Cerilliant
Colorcon
Boehringer Ingelheim

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,811,731

« Back to Dashboard

Summary for Patent: 4,811,731

Title: Devices for administering medicaments to patients
Abstract:A device is provided for administering medicaments in solid finely divided form to patients. The device comprising a housing, a tray mounted in the housing and movable between first and second positions relative to the housing, a support disc provided on the tray and adapted to receive a carrier provided with at least one medicament container. A plunger is operable to penetrate a container registered therewith to open the container, movement of the tray from its first to its second position being such as to cause the support to bring a container into registration with the plunger. Air enters through an air inlet and there is an outlet through which a patient can inhale air having medicament therein.
Inventor(s): Newell; Robert E. (Pinner, GB2), Rand; Paul K. (Nitchin, GB2), Fitzsimmons; Robert A. (Barnard Castle, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:06/891,536
Patent Claim Types:
see list of patent claims
Composition; Device;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,811,731

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8519141Jul 30, 1985
United Kingdom8525067Oct 10, 1985

International Patent Family for Patent: 4,811,731

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary199306► Subscribe
Ireland862022► Subscribe
Ireland59026► Subscribe
Israel79550► Subscribe
HungaryT44182► Subscribe
Canada1272917► Subscribe
Switzerland672600► Subscribe
Cyprus1481► Subscribe
Germany3625685► Subscribe
Germany3682457► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Covington
Julphar
Novartis
Harvard Business School
Healthtrust
Express Scripts
McKinsey
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot